Physician Profile
Amie G. Sessa, M.D. is a healthcare provider in Lutherville, MD specializing in dermatology. Amie trained at University of Maryland School of Medicine, graduating in 2009. Medicare claims data shows Amie provided 6,244 services to 3,727 patients. The services billed most often include destruction of precancer skin growth, 2-14 growths, established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, and destruction of precancer skin growth, 1 growth. This provider record is associated with NPI 1194950279.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
1447 YORK RD SUITE 301
Lutherville, MD 21093
Within Dermatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Acne and follicular disorders
Eczema and inflammatory skin disease
Infections and infestations
Pigment, growths, and benign lesions
Skin cancer
Urticaria, itch, and vascular
Autoimmune and connective tissue
Infections
Rashes & allergy
Skin growths
Most searched procedures
Diagnostic procedures
Lesion treatment
Medical dermatology treatment
Cosmetic
Cosmetic and minor surgery
Cosmetic dermatology
Diagnostic
General dermatology
Infections
Medical dermatology
Nails & hair
Skin cancer surgery
Skin growths
6,244 services · 3,727 patients · 17 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
2,203 | More often than most peers in Dermatology |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
878 | More than most peers in Dermatology |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
491 | More than most peers in Dermatology |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
260 | More often than most peers in Dermatology |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
44 | As often as other peers in Dermatology |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Procedure | 17262 |
37 | As often as other peers in Dermatology |
| Destruction of precancer skin growth, 15 or more growths | Procedure | 17004 |
21 | Less often than most peers in Dermatology |
| Injection into skin growth, 1-7 growths | Procedure | 11900 |
19 | Less often than most peers in Dermatology |
| Administration of chemotherapy into growth, 1-7 | Treatment | 96405 |
28 | As often as other peers in Dermatology |
| Injection, fluorouracil, 500 mg | Drug given | J9190 |
28 | As often as other peers in Dermatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Amie G. Sessa is a dermatologist (skin doctor) in Lutherville, MD. That is the designation recorded for this NPI in the federal registry, where it is listed as “Dermatology”.
NPI registry
Amie G. Sessa is listed at 1447 York Rd Suite 301, Lutherville, MD 21093. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (410) 252-9090. Contact the office directly to confirm availability and scheduling.
NPI registry
Amie G. Sessa's National Provider Identifier is 1194950279. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Amie G. Sessa attended University of Maryland School of Medicine, graduating in 2009. This comes from the CMS National Downloadable File.
CMS public data
Amie G. Sessa has 17 years experience. Calculated from a graduation year of 2009, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Amie G. Sessa performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of precancer skin growth, 1 growth and destruction of skin growth, 1-14 growths; provides treatments such as administration of chemotherapy into growth, 1-7, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Amie G. Sessa. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.